Loading…
← CockpitCompetitor Analysis › BALAMINES.NS Balaji Amines LimitedOpen in the cockpit ↗

Balaji Amines LimitedBALAMINES.NSCompetitor analysis, valuation and peers

India · INR·Chemicals›Chemicals: Specialty
Momentum neutral 40
Mkt cap
$604M
US dollars, full cap
Free float
32%
of shares outstanding
$/day
$3.40M
20-day average traded
Fwd P/E
36.2×
forward earnings
ROIC−WACC
-8.8 pp
WACC 18.6%
Hurdle
n/a
no reverse DCF
Next earnings
89 days
3 Feb 2027
Close · INR₹1,762
1D-1.8%
1W-0.2%
1M-18.3%
3M-16.1%
6M+15.4%
YTD+57.1%
1Y+24.7%
ATR %5.1%
Beta1.27
52w lowhigh33.0% off high

What Balaji Amines does

Employees: 1,266

Balaji Amines at a glance

Size Balaji Amines (BALAMINES.NS) is an India Materials company (Chemicals: Specialty) with a market value of $604M, the 777th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹1,762 on 6 Nov 2026.

Performance Over six months the shares gained 15.4%, against -15.4% for the median peer and 0.0% for the India market (cap-weighted) — 2nd highest of 21 in its peer set.

Growth Revenue grew 20.9% over the last twelve months (peer median +6.2%); the operating margin is 18.9% (peer median 5.7%).

Valuation It trades at 36.2× forward earnings against a peer median of 14.6× (2nd most expensive of 10).

Capital Return on invested capital runs 8.8 points below its cost of capital (18.6% WACC).

Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).

Relative performance

10015011 May 202611 Aug 20266 Nov 2026BALAMINES.NS 118Peer median 84
Six months, rebased to 100: Balaji Amines against the median of its 20 peers (local-currency closes).

Balaji Amines financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹16.5B₹14.1B₹13.9B₹16.1B₹23.4B
Revenue growth—+1%-14%-31%—
Gross profit₹5.74B₹2.71B₹2.75B₹3.50B₹6.55B
EBITDA₹3.68B₹2.54B₹2.36B₹3.07B₹6.05B
Net income₹2.37B₹1.67B₹1.58B₹2.05B₹3.26B
Free cash flown/a-₹3.44B₹875M₹966M₹2.54B
Capital expendituren/a₹5.40B₹1.87B₹2.55B₹1.20B
Total debt₹1.61B₹1.33B₹110M₹197M₹576M

Quarterly statements and history in the cockpit →

Balaji Amines competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%0%002637170940286032763015576030513007581711002805301538603790285130688196300107477080140024693004784971002584BALAMINES.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Balaji Amines is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%20×40×002637402830075830153828513068819647700024694971BALAMINES.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Balaji Amines is the large dot.

Balaji Amines competitors and peer comparison

How Balaji Amines compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Balaji Amines against its 20 peers (data as of 6 Nov 2026)
MeasureBALAMINES.NSPeer medianRank in peer set
1-month return-18.3%-9.9%6th lowest of 21
6-month return+15.4%-15.4%2nd highest of 21
Distance from 52-week high-33.0%-40.2%6th highest of 21
Revenue growth (TTM)+20.9%+6.2%7th highest of 21
Operating margin18.9%5.7%3rd highest of 21
Forward P/E36.2×14.6×2nd most expensive of 10
ROIC minus cost of capital-8.8 pp-1.9 pp2nd lowest of 21
EV / EBITDA15.8×12.4×3rd most expensive of 9
Net debt / EBITDA-0.2×1.0×4th least indebted of 10

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Balaji Amines BALAMINES.NSIndia$604M+15%+21%19%36.2×n/an/a
Zanyu Technology 002637.SZChina$605M-34%-3%3%9.3×-0.9%+11.0%
Formosan Union Chemical 1709.TWTaiwan$607M+128%-3%14%n/a-1.6%+1.2%
Ishihara Sangyo Kaisha 4028.TJapan$596M-22%+1%11%9.5×1.1%+8.8%
Jiangsu Hengxing New Material Technology 603276.SSChina$596M+7%+29%8%n/a18.5%+15.2%
Cytech 301557.SZChina$595M-3%+13%7%n/an/an/a
Guangzhou Lushan New Materials 603051.SSChina$595M+5%-5%0%n/a32.5%+8.5%
Anshan Hifichem 300758.SZChina$615M-22%+11%9%45.2×15.5%+8.2%
Everlight Chemical Industrial 1711.TWTaiwan$593M-45%-2%-1%n/an/an/a
Shandong Fengyuan Chemical 002805.SZChina$591M-38%+281%1%n/an/an/a
Shenzhen Jdd Tech New Material 301538.SZChina$591M-33%+10%18%14.6×15.3%+25.6%
Argus (Shanghai) Textile Chemicals 603790.SSChina$618M-11%+21%14%n/a11.7%+0.7%
Skchem 285130.KSSouth Korea$588M-27%+27%0%33.8×n/an/a
Longyan Zhuoyue New Energy 688196.SSChina$622M-38%+2%1%35.0×n/an/a
Hebei Jianxin Chemical Industry 300107.SZChina$581M-6%+39%11%n/an/an/a
Allied Supreme 4770.TWTaiwan$629M+12%-15%19%14.2×3.4%+12.4%
Chori 8014.TJapan$629M-6%+3%4%n/a-13.4%+6.7%
Shandong Sunway Chemical 002469.SZChina$579M-20%-19%3%24.6×n/an/a
Hangzhou Gaoxin Materials Technology 300478.SZChina$631M+11%-21%-9%n/a30.8%-0.9%
MEC 4971.TJapan$578M-47%+29%31%14.4×17.2%+11.9%
Xilong Scientific 002584.SZChina$632M-11%+23%1%n/an/an/a

Questions

Which companies are Balaji Amines's closest peers?
The cockpit's peer set: Zanyu Technology (002637.SZ), Formosan Union Chemical (1709.TW), Ishihara Sangyo Kaisha (4028.T), Jiangsu Hengxing New Material Technology (603276.SS), Cytech (301557.SZ), Guangzhou Lushan New Materials (603051.SS), Anshan Hifichem (300758.SZ), Everlight Chemical Industrial (1711.TW).
Is Balaji Amines expensive compared with its peers?
On forward p/e it trades at 36.2× against a peer median of 14.6×, 2nd most expensive of 10 in its peer set.
How has Balaji Amines stock performed?
Over six months to 6 Nov 2026 the shares returned +15.4% against -15.4% for the median peer; over one year +24.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.